Loading markets…

Tango Therapeutics, Inc. (TNGX) forecast

Tango Therapeutics, Inc. (TNGX) forecast: price $27.29, trailing P/E -29.71, forward P/E 30.47. How to read the street's path.

$27.29Price
$4.60BMarket cap
-29.71P/E ?
30.47Forward P/E ?
0.00%Dividend yield ?

The live TNGX price is $27.29. Trailing P/E is -29.71 and forward P/E is 30.47. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the TNGX forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full TNGX quote · Dividends · Price prediction · Academy

Questions

What is TNGX's forward P/E?

The latest forward P/E on Stocklytics is 30.47, against a trailing P/E of -29.71 and a price of $27.29.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.